AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 OCT 3 - (NewsRx.com & NewsRx.net) -- Symbollon Pharmaceuticals, Inc., (SYMBA) announced a net loss for the quarter ended June 30, 2002.
For the 3 months ended June 30, 2002, the company reported a net loss of $124,367, or a diluted loss per share of $0.03, compared with a net loss of $408,893, or a diluted loss per share of $0.10 in the prior year.
For the 6 months ended June 30, 2002, the company reported a net loss of $315,386, or a diluted loss per share of $0.08, compared with a net loss of $734,317, or a diluted loss per share of $0.17 in the prior year. The decreased loss reflected primarily from decreased research and development expenses, decreased general and administrative expenses and increased ...
Source: HighBeam Research, Symbollon Pharmaceuticals announces second quarter 2002...